BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03249792-completion@plaintrial.com
DTSTAMP:20261029T044826Z
DTSTART;VALUE=DATE:20230222
SUMMARY:Study of MK-2118 Administered as Intratumoral Injection as Monother
 apy and in Combination With Pembrolizumab (MK-3475) or by Subcutaneous Inj
 ection in Combination With Pembrolizumab in the Treatment of Adults With A
 dvanced/Metastatic Solid Tumors or Lymphomas (MK-2118-001) — estimated c
 ompletion date
DESCRIPTION:Terminated. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT03249792
URL:https://plaintrial.com/trial/NCT03249792
END:VEVENT
END:VCALENDAR